APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Methotrexate Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Methotrexate Injection Market Outlook and Growth Opportunities 2026

Report ID 17401281042 January 2026194 pages

Choose your research edition.

Industry ResearchMethotrexate Injection Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Methotrexate Injection Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Methotrexate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Methotrexate Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Methotrexate Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Methotrexate Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Methotrexate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Methotrexate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Methotrexate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Methotrexate Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Methotrexate Injection market include Accord, Get Well Pharmaceutical, Hikma, Fresenius Kabi, Guangdong Lingnan Pharma, Hengrui Medicine, Pfizer, Mylan and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Methotrexate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Methotrexate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Methotrexate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Methotrexate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Methotrexate Injection Segment by Company

Accord

Get Well Pharmaceutical

Hikma

Fresenius Kabi

Guangdong Lingnan Pharma

Hengrui Medicine

Pfizer

Mylan

Qilu Pharmaceutical

Shanxi Pude Pharma

Sichuan Huiyu Pharma

Teva

Youcare Pharmaceutical Group

Methotrexate Injection Segment by Type

Preservative-Free

With Preservative

Methotrexate Injection Segment by Application

Specialty Clinic

Hospital

Recovry Center

Methotrexate Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Methotrexate Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Methotrexate Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Methotrexate Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Methotrexate Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Methotrexate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Methotrexate Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Methotrexate Injection industry.

Chapter 3: Detailed analysis of Methotrexate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Methotrexate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Methotrexate Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Methotrexate Injection Industry Trends Table 2. Methotrexate Injection Industry Drivers Table 3. Methotrexate Injection Industry Opportunities and Challenges Table 4. Methotrexate Injection Industry Restraints Table 5. Global Methotrexate Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Methotrexate Injection Revenue Share by Company (2021-2026) Table 7. Global Methotrexate Injection Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Methotrexate Injection Sales Volume Share by Company (2021-2026) Table 9. Global Methotrexate Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Methotrexate Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Methotrexate Injection Key Company Manufacturing Base & Headquarters Table 12. Global Methotrexate Injection Company, Product Type & Application Table 13. Global Methotrexate Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Methotrexate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Preservative-Free Table 18. Significant Companies of With Preservative Table 19. Global Methotrexate Injection Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Methotrexate Injection Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Methotrexate Injection Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Methotrexate Injection Sales Volume Share by Type (2021-2026) Table 23. Global Methotrexate Injection Sales Volume Share by Type (2027-2032) Table 24. Global Methotrexate Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Methotrexate Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Methotrexate Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Methotrexate Injection Sales Value Share by Type (2021-2026) Table 28. Global Methotrexate Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Specialty Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Recovry Center Table 32. Global Methotrexate Injection Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Methotrexate Injection Sales Volume by Application (2021-2026) & (W Units) Table 34. Global Methotrexate Injection Sales Volume by Application (2027-2032) & (W Units) Table 35. Global Methotrexate Injection Sales Volume Share by Application (2021-2026) Table 36. Global Methotrexate Injection Sales Volume Share by Application (2027-2032) Table 37. Global Methotrexate Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Methotrexate Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Methotrexate Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Methotrexate Injection Sales Value Share by Application (2021-2026) Table 41. Global Methotrexate Injection Sales Value Share by Application (2027-2032) Table 42. Global Methotrexate Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Methotrexate Injection Sales by Region (2021-2026) & (W Units) Table 44. Global Methotrexate Injection Sales Market Share by Region (2021-2026) Table 45. Global Methotrexate Injection Sales by Region (2027-2032) & (W Units) Table 46. Global Methotrexate Injection Sales Market Share by Region (2027-2032) Table 47. Global Methotrexate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Methotrexate Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Methotrexate Injection Sales Value Share by Region (2021-2026) Table 50. Global Methotrexate Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Methotrexate Injection Sales Value Share by Region (2027-2032) Table 52. Global Methotrexate Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Methotrexate Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Methotrexate Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Global Methotrexate Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Methotrexate Injection Sales by Country (2021-2026) & (W Units) Table 57. Global Methotrexate Injection Sales Market Share by Country (2021-2026) Table 58. Global Methotrexate Injection Sales by Country (2027-2032) & (W Units) Table 59. Global Methotrexate Injection Sales Market Share by Country (2027-2032) Table 60. Global Methotrexate Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Methotrexate Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Methotrexate Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Methotrexate Injection Sales Value Market Share by Country (2027-2032) Table 64. Accord Company Information Table 65. Accord Business Overview Table 66. Accord Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Accord Methotrexate Injection Product Portfolio Table 68. Accord Recent Development Table 69. Get Well Pharmaceutical Company Information Table 70. Get Well Pharmaceutical Business Overview Table 71. Get Well Pharmaceutical Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Get Well Pharmaceutical Methotrexate Injection Product Portfolio Table 73. Get Well Pharmaceutical Recent Development Table 74. Hikma Company Information Table 75. Hikma Business Overview Table 76. Hikma Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Hikma Methotrexate Injection Product Portfolio Table 78. Hikma Recent Development Table 79. Fresenius Kabi Company Information Table 80. Fresenius Kabi Business Overview Table 81. Fresenius Kabi Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Fresenius Kabi Methotrexate Injection Product Portfolio Table 83. Fresenius Kabi Recent Development Table 84. Guangdong Lingnan Pharma Company Information Table 85. Guangdong Lingnan Pharma Business Overview Table 86. Guangdong Lingnan Pharma Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Guangdong Lingnan Pharma Methotrexate Injection Product Portfolio Table 88. Guangdong Lingnan Pharma Recent Development Table 89. Hengrui Medicine Company Information Table 90. Hengrui Medicine Business Overview Table 91. Hengrui Medicine Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Hengrui Medicine Methotrexate Injection Product Portfolio Table 93. Hengrui Medicine Recent Development Table 94. Pfizer Company Information Table 95. Pfizer Business Overview Table 96. Pfizer Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Pfizer Methotrexate Injection Product Portfolio Table 98. Pfizer Recent Development Table 99. Mylan Company Information Table 100. Mylan Business Overview Table 101. Mylan Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Mylan Methotrexate Injection Product Portfolio Table 103. Mylan Recent Development Table 104. Qilu Pharmaceutical Company Information Table 105. Qilu Pharmaceutical Business Overview Table 106. Qilu Pharmaceutical Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Qilu Pharmaceutical Methotrexate Injection Product Portfolio Table 108. Qilu Pharmaceutical Recent Development Table 109. Shanxi Pude Pharma Company Information Table 110. Shanxi Pude Pharma Business Overview Table 111. Shanxi Pude Pharma Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Shanxi Pude Pharma Methotrexate Injection Product Portfolio Table 113. Shanxi Pude Pharma Recent Development Table 114. Sichuan Huiyu Pharma Company Information Table 115. Sichuan Huiyu Pharma Business Overview Table 116. Sichuan Huiyu Pharma Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Sichuan Huiyu Pharma Methotrexate Injection Product Portfolio Table 118. Sichuan Huiyu Pharma Recent Development Table 119. Teva Company Information Table 120. Teva Business Overview Table 121. Teva Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Teva Methotrexate Injection Product Portfolio Table 123. Teva Recent Development Table 124. Youcare Pharmaceutical Group Company Information Table 125. Youcare Pharmaceutical Group Business Overview Table 126. Youcare Pharmaceutical Group Methotrexate Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Youcare Pharmaceutical Group Methotrexate Injection Product Portfolio Table 128. Youcare Pharmaceutical Group Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Methotrexate Injection Distributors List Table 132. Methotrexate Injection Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Methotrexate Injection Product Image Figure 2. Global Methotrexate Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Methotrexate Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Methotrexate Injection Sales (2021-2032) & (W Units) Figure 5. Global Methotrexate Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Methotrexate Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Preservative-Free Image Figure 10. With Preservative Image Figure 11. Global Methotrexate Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Methotrexate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Methotrexate Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Methotrexate Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Methotrexate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Methotrexate Injection Sales Value Share by Type (2021-2032) Figure 17. Specialty Clinic Image Figure 18. Hospital Image Figure 19. Recovry Center Image Figure 20. Global Methotrexate Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Methotrexate Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Methotrexate Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Methotrexate Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Methotrexate Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Methotrexate Injection Sales Value Share by Application (2021-2032) Figure 26. Global Methotrexate Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Methotrexate Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Methotrexate Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Methotrexate Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Methotrexate Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Methotrexate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Methotrexate Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Methotrexate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Methotrexate Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Methotrexate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Methotrexate Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Methotrexate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Methotrexate Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Methotrexate Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Methotrexate Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Methotrexate Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Methotrexate Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Methotrexate Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Methotrexate Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Preservative-Free
  • With Preservative
Applications
  • Specialty Clinic
  • Hospital
  • Recovry Center
Companies covered
  • Accord
  • Get Well Pharmaceutical
  • Hikma
  • Fresenius Kabi
  • Guangdong Lingnan Pharma
  • Hengrui Medicine
  • Pfizer
  • Mylan
  • Qilu Pharmaceutical
  • Shanxi Pude Pharma
  • Sichuan Huiyu Pharma
  • Teva
  • Youcare Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Methotrexate Injection Sales Value (2021-2032)
  4. 1.2.2 Global Methotrexate Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Methotrexate Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Methotrexate Injection Market Dynamics
  1. 2.1 Methotrexate Injection Industry Trends
  2. 2.2 Methotrexate Injection Industry Drivers
  3. 2.3 Methotrexate Injection Industry Opportunities and Challenges
  4. 2.4 Methotrexate Injection Industry Restraints
3 Methotrexate Injection Market by Company
  1. 3.1 Global Methotrexate Injection Company Revenue Ranking in 2025
  2. 3.2 Global Methotrexate Injection Revenue by Company (2021-2026)
  3. 3.3 Global Methotrexate Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Methotrexate Injection Average Price by Company (2021-2026)
  5. 3.5 Global Methotrexate Injection Company Ranking (2024-2026)
  6. 3.6 Global Methotrexate Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Methotrexate Injection Company Product Type and Application
  8. 3.8 Global Methotrexate Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Methotrexate Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Methotrexate Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Methotrexate Injection Market by Type
  1. 4.1 Methotrexate Injection Type Introduction
  2. 4.1.1 Preservative-Free
  3. 4.1.2 With Preservative
  4. 4.2 Global Methotrexate Injection Sales Volume by Type
  5. 4.2.1 Global Methotrexate Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Methotrexate Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Methotrexate Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Methotrexate Injection Sales Value by Type
  9. 4.3.1 Global Methotrexate Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Methotrexate Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Methotrexate Injection Sales Value Share by Type (2021-2032)
5 Methotrexate Injection Market by Application
  1. 5.1 Methotrexate Injection Application Introduction
  2. 5.1.1 Specialty Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovry Center
  5. 5.2 Global Methotrexate Injection Sales Volume by Application
  6. 5.2.1 Global Methotrexate Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Methotrexate Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Methotrexate Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Methotrexate Injection Sales Value by Application
  10. 5.3.1 Global Methotrexate Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Methotrexate Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Methotrexate Injection Sales Value Share by Application (2021-2032)
6 Methotrexate Injection Regional Sales and Value Analysis
  1. 6.1 Global Methotrexate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Methotrexate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Methotrexate Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Methotrexate Injection Sales by Region (2027-2032)
  5. 6.3 Global Methotrexate Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Methotrexate Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Methotrexate Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Methotrexate Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Methotrexate Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Methotrexate Injection Sales Value (2021-2032)
  12. 6.6.2 North America Methotrexate Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Methotrexate Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Methotrexate Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Methotrexate Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Methotrexate Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Methotrexate Injection Sales Value (2021-2032)
  21. 6.9.2 South America Methotrexate Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Methotrexate Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Methotrexate Injection Sales Value Share by Country, 2025 VS 2032
7 Methotrexate Injection Country-level Sales and Value Analysis
  1. 7.1 Global Methotrexate Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Methotrexate Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Methotrexate Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Methotrexate Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Methotrexate Injection Sales by Country (2027-2032)
  6. 7.4 Global Methotrexate Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Methotrexate Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Methotrexate Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Methotrexate Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Methotrexate Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Methotrexate Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Methotrexate Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Methotrexate Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Methotrexate Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Methotrexate Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Methotrexate Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Methotrexate Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Methotrexate Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Methotrexate Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Methotrexate Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Methotrexate Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Methotrexate Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Methotrexate Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Methotrexate Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Methotrexate Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Methotrexate Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Methotrexate Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Methotrexate Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Methotrexate Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Methotrexate Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Methotrexate Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Methotrexate Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Methotrexate Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Methotrexate Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Methotrexate Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Methotrexate Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Methotrexate Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Methotrexate Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Accord
  2. 8.1.1 Accord Company Information
  3. 8.1.2 Accord Business Overview
  4. 8.1.3 Accord Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Accord Methotrexate Injection Product Portfolio
  6. 8.1.5 Accord Recent Developments
  7. 8.2 Get Well Pharmaceutical
  8. 8.2.1 Get Well Pharmaceutical Company Information
  9. 8.2.2 Get Well Pharmaceutical Business Overview
  10. 8.2.3 Get Well Pharmaceutical Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Get Well Pharmaceutical Methotrexate Injection Product Portfolio
  12. 8.2.5 Get Well Pharmaceutical Recent Developments
  13. 8.3 Hikma
  14. 8.3.1 Hikma Company Information
  15. 8.3.2 Hikma Business Overview
  16. 8.3.3 Hikma Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hikma Methotrexate Injection Product Portfolio
  18. 8.3.5 Hikma Recent Developments
  19. 8.4 Fresenius Kabi
  20. 8.4.1 Fresenius Kabi Company Information
  21. 8.4.2 Fresenius Kabi Business Overview
  22. 8.4.3 Fresenius Kabi Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Kabi Methotrexate Injection Product Portfolio
  24. 8.4.5 Fresenius Kabi Recent Developments
  25. 8.5 Guangdong Lingnan Pharma
  26. 8.5.1 Guangdong Lingnan Pharma Company Information
  27. 8.5.2 Guangdong Lingnan Pharma Business Overview
  28. 8.5.3 Guangdong Lingnan Pharma Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Guangdong Lingnan Pharma Methotrexate Injection Product Portfolio
  30. 8.5.5 Guangdong Lingnan Pharma Recent Developments
  31. 8.6 Hengrui Medicine
  32. 8.6.1 Hengrui Medicine Company Information
  33. 8.6.2 Hengrui Medicine Business Overview
  34. 8.6.3 Hengrui Medicine Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hengrui Medicine Methotrexate Injection Product Portfolio
  36. 8.6.5 Hengrui Medicine Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Methotrexate Injection Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Mylan
  44. 8.8.1 Mylan Company Information
  45. 8.8.2 Mylan Business Overview
  46. 8.8.3 Mylan Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mylan Methotrexate Injection Product Portfolio
  48. 8.8.5 Mylan Recent Developments
  49. 8.9 Qilu Pharmaceutical
  50. 8.9.1 Qilu Pharmaceutical Company Information
  51. 8.9.2 Qilu Pharmaceutical Business Overview
  52. 8.9.3 Qilu Pharmaceutical Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Qilu Pharmaceutical Methotrexate Injection Product Portfolio
  54. 8.9.5 Qilu Pharmaceutical Recent Developments
  55. 8.10 Shanxi Pude Pharma
  56. 8.10.1 Shanxi Pude Pharma Company Information
  57. 8.10.2 Shanxi Pude Pharma Business Overview
  58. 8.10.3 Shanxi Pude Pharma Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shanxi Pude Pharma Methotrexate Injection Product Portfolio
  60. 8.10.5 Shanxi Pude Pharma Recent Developments
  61. 8.11 Sichuan Huiyu Pharma
  62. 8.11.1 Sichuan Huiyu Pharma Company Information
  63. 8.11.2 Sichuan Huiyu Pharma Business Overview
  64. 8.11.3 Sichuan Huiyu Pharma Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sichuan Huiyu Pharma Methotrexate Injection Product Portfolio
  66. 8.11.5 Sichuan Huiyu Pharma Recent Developments
  67. 8.12 Teva
  68. 8.12.1 Teva Company Information
  69. 8.12.2 Teva Business Overview
  70. 8.12.3 Teva Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Teva Methotrexate Injection Product Portfolio
  72. 8.12.5 Teva Recent Developments
  73. 8.13 Youcare Pharmaceutical Group
  74. 8.13.1 Youcare Pharmaceutical Group Company Information
  75. 8.13.2 Youcare Pharmaceutical Group Business Overview
  76. 8.13.3 Youcare Pharmaceutical Group Methotrexate Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Youcare Pharmaceutical Group Methotrexate Injection Product Portfolio
  78. 8.13.5 Youcare Pharmaceutical Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Methotrexate Injection Value Chain Analysis
  2. 9.1.1 Methotrexate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Methotrexate Injection Sales Mode & Process
  6. 9.2 Methotrexate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Methotrexate Injection Distributors
  9. 9.2.3 Methotrexate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst